Finally, in vivo experiments confirmed that the overexpression of OIP5-AS1 promoted the growth of HCC xenografts, induced EMT of the HCC cells, and upregulated SNAI1 expression. The gene discussed is OIP5; the disease is hepatocellular carcinoma.